SR-302

SR-302 : Inhibitor of DDR1, DDR2, MAPK11, MAPK14

Structure

Information

  • DDR1
  • DDR2
  • MAPK11
  • MAPK14
  • Inhibitor
  • 100 nM

In Vitro Validations

Uniprot ID: Q08345
Target Class: Kinase
Target SubClass: CMGC
Potency: IC50
Potency Value: 53.3 nM
Potency Assay: Enzyme kinetic assay from"Reaction Biology" (ATP conc.: 100 µM)
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Epithelial discoidin domain-containing receptor 1, ...

DOI Reference: 10.1021/acs.jmedchem.1c00868

In Cell Validations

In Vivo Data

No in Vivo Validations

Off-Target Selectivity Assesments

Probe Selectivity in Vitro:
Closest off-targets found in KinomeScan: ABL1, RIPK2, RPS6KA5, CHEK2, STK38L; for all IC50 > 25 µM (> 125 fold selective) in NanoBRET assay
I have extra information to add

SERP ratings and comments


SERP+ Ratings

In Cell Rating

SERP+ Comments:

SR-302 shows good potency for DDR1 and DDR2 in vitro determined by enyzme kinetic assay (IC50 = 53.3 nM and IC50 = 0.75 nM). Activity in cells was investigated via NanoBRET which delivered IC50 = 23 nM and IC50 = 18 nM. Kinome wide selectivity screening (0.1 uM inhibitor concentration) showed off-targets p38alfa (IC50 = 125 nM) and p38beta (IC50 = 196 nM) with 10fold decreased potency. Due to high IC50 values on the off-targets and very high in cellulo potency, SR-302 is a valuable tool compound for studying biology of DDR1/2 in combination with other orthogonal probes.

(last updated: 17 Jun 2024 )